On Apr. 8, 2025, the National Security Commission on Emerging Biotechnology delivered its major report and action plan…
On Mar. 27, 2025, a Nature survey of more than 1,200 scientists, three-quarters of the total respondents are…
On Mar. 3, 2025, LifeScienceHistory.com: Where history is made daily announces the release of a rewritten hit rock…
On Jan. 21, 2025, Rice University announced that four research groups are part of an inaugural cohort of…
On Jan. 14, 2025, The U.S. Department of Defense (DoD) has awarded up to $11.9 million to Oregon…
On Dec. 4, 2024, artificial intelligence (AI) researchers, in an effort to automate scientific discovery announced they have…
On Nov. 27, 2024, researchers at the University of Illinois Urbana-Champaign announced they had developed a nanorobotic hand…
On Nov. 12, 2024, researchers led by Nico Sommerdijk from Radboud university medical center in Nijmegen (Netherlands) announced…
On Oct. 30, 2024, an international research team led by the University of Bonn reported results of a…
On Oct. 11, 2024, scientists at the Korea Advanced Institute of Science and Technology (KAIST) announced they had…
On Oct. 1, 2024, the National Academy of Medicine (NAM) announced a study showing that although the U.S….
On Apr. 26, 2024, engineers at Washington University in St. Louis announced a new imaging technique that give…
On Sept. 15, 2023, researchers at the National Institute of Allergy and Infectious Diseases (NIAID) announced they had…
On Mar. 28, 2023, the American Chemical Society awarded The Priestley Medal to Cato T. Laurencin “to recognize distinguished…
On Oct. 25, 2022, Pacific Northwest National Laboratory (PNNL) announced that scientists have shown that they can detect…
On Feb. 10, 2022, Novavax announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, achieved its primary effectiveness…
On Jan. 28, 2022, Novavax and Israel’s Ministry of Health announced an agreement for the purchase of NVX-CoV2373,…
On Jan. 10, 2022, Novavax and Serum Institute of India announced a regulatory submission to the South African…
On Jan. 4, 2022, Tonix Pharmaceuticals announced an exclusive option agreement and research collaboration with Kansas State University…
On Dec. 28, 2021, Novavax and Serum Institute of India announced that the Drugs Controller General of India…
On Dec. 23, 2021, Novavax and SK bioscience announced the expansion of the companies’ collaboration and license agreements…
On Dec. 21, 2021, Novavax announced that the first booster doses of NVX-CoV2373, the company’s recombinant nanoparticle protein-based…
On Dec. 20, 2021, Novavax announced that the World Health Organization (WHO) had granted a second Emergency Use…
On Dec. 17, 2021, Novavax and SK bioscience announced that the World Health Organization (WHO) had granted Emergency…
On Dec. 15, 2021, Novavax announced the submission of a New Drug Application to the Ministry of Health,…
On Dec. 7, 2021, Rockefeller University scientists announced a study had demonstrated the therapeutic potential of an unusual…
On Nov. 17, 2021, Novavax and and Serum Institute of India announced that the Philippine Food and Drug…
On Nov. 17, 2021, Zosano Pharma announced that the Philippine Food and Drug Administration had granted emergency use…
On Nov. 15, 2021, Novavax and SK bioscience announced submission of a Biologics License Application (BLA) for Novavax’…
On Sept. 21, 2021, the Medicines Patent Pool (MPP) announced that it had signed a licence agreement with…